bendamustine hydrochloride has been researched along with Lymphoma, T-Cell in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 3 (37.50) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hui, M | 1 |
| Feng, X; Gao, Y; Jin, M; Li, H; Li, Z; Shi, C; Song, W; Zhang, L; Zhang, M | 1 |
| Jin, M; Li, Z; Shi, C; Song, Y; Zhang, M; Zhang, P | 1 |
| Kempf, W; Mitteldorf, C; Tronnier, M; Wollert, E | 1 |
| Gatt, ME; Goldschmidt, N; Gural, A; Lavie, D; Lebel, E; Nachmias, B; Saban, R; Shaulov, A | 1 |
| Baldini, L; Fanin, R; Ferreri, AJ; Goldaniga, M; Grossi, A; Luminari, S; Salvi, F; Volpetti, S; Zaja, F; Zambello, R | 1 |
| Burckhardt, G; Hagos, Y; Hundertmark, P; Marada, VV; Shnitsar, V; Wulf, G | 1 |
| Albiero, E; Bernardi, M; Castegnaro, S; Chieregato, K; Madeo, D; Rodeghiero, F; Visco, C; Zanon, C | 1 |
8 other study(ies) available for bendamustine hydrochloride and Lymphoma, T-Cell
| Article | Year |
|---|---|
Indolent T cell lymphoma involving the central nervous system and successfully treated by bendamustine.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Central Nervous System; Humans; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Nitrogen Mustard Compounds; Rituximab | 2022 |
The potential efficacy and mechanism of bendamustine in entra-nodal NK/T cell lymphoma.
Topics: Animals; Apoptosis; Ataxia Telangiectasia Mutated Proteins; Bendamustine Hydrochloride; Caspases; Cell Line, Tumor; Cell Proliferation; Cyclin B1; Etoposide; Humans; Lymphoma; Lymphoma, T-Cell; Mice; Poly(ADP-ribose) Polymerase Inhibitors; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Ribose; Tumor Suppressor Protein p53 | 2022 |
Brentuxinmab vedotin, alone or combine with bendamustine in the treatment of natural killer T cell lymphoma.
Topics: Bendamustine Hydrochloride; Humans; Lymphoma; Lymphoma, T-Cell; Natural Killer T-Cells | 2022 |
Generalized maculopapular and vesicular rash.
Topics: Acyclovir; Aged; Bendamustine Hydrochloride; Drug Eruptions; Epidermis; Herpes Zoster; Humans; Immunoblastic Lymphadenopathy; Keratinocytes; Lymphocytes; Lymphoma, T-Cell; Male; Programmed Cell Death 1 Receptor; Skin | 2018 |
Romidepsin-Bendamustine Combination for Relapsed/Refractory T Cell Lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Depsipeptides; Disease-Free Survival; Female; Follow-Up Studies; Humans; Lymphoma, T-Cell; Male; Middle Aged; Recurrence; Survival Rate | 2019 |
Bendamustine salvage therapy for T cell neoplasms.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Bendamustine Hydrochloride; Female; Follow-Up Studies; Humans; Leukemia, Large Granular Lymphocytic; Lymphoma, T-Cell; Male; Middle Aged; Nitrogen Mustard Compounds; Retrospective Studies; Salvage Therapy | 2013 |
Renal human organic anion transporter 3 increases the susceptibility of lymphoma cells to bendamustine uptake.
Topics: Antineoplastic Agents, Alkylating; Apoptosis; Bendamustine Hydrochloride; Cell Proliferation; Chlorambucil; Dose-Response Relationship, Drug; Estrone; HEK293 Cells; Humans; Jurkat Cells; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, T-Cell; Melphalan; Nitrogen Mustard Compounds; Organic Anion Transport Protein 1; Organic Anion Transporters, Sodium-Independent; p-Aminohippuric Acid; Transfection; Tumor Cells, Cultured | 2015 |
Cytosine arabinoside potentiates the apoptotic effect of bendamustine on several B- and T-cell leukemia/lymphoma cells and cell lines.
Topics: Antimetabolites, Antineoplastic; Apoptosis; Bendamustine Hydrochloride; Cell Cycle; Cell Line, Tumor; Cytarabine; Humans; Leukemia; Leukemia, B-Cell; Leukemia, T-Cell; Lymphoma; Lymphoma, B-Cell; Lymphoma, T-Cell; Nitrogen Mustard Compounds | 2012 |